| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Syntenins | 12 | 2023 | 12 | 2.850 |
Why?
|
| Interleukins | 9 | 2024 | 108 | 2.070 |
Why?
|
| Triticum | 9 | 2025 | 19 | 1.810 |
Why?
|
| Neoplasms | 8 | 2021 | 756 | 1.460 |
Why?
|
| DNA-Binding Proteins | 5 | 2014 | 482 | 1.360 |
Why?
|
| Melanoma | 6 | 2023 | 140 | 1.350 |
Why?
|
| MicroRNAs | 3 | 2019 | 278 | 1.350 |
Why?
|
| Apoptosis | 9 | 2021 | 737 | 1.310 |
Why?
|
| Basidiomycota | 3 | 2023 | 6 | 1.280 |
Why?
|
| Prostatic Neoplasms | 6 | 2023 | 270 | 1.200 |
Why?
|
| Proto-Oncogenes | 5 | 2014 | 15 | 1.140 |
Why?
|
| Transcription Factors | 4 | 2014 | 511 | 1.050 |
Why?
|
| Seedlings | 3 | 2023 | 7 | 0.970 |
Why?
|
| bcl-X Protein | 3 | 2014 | 34 | 0.950 |
Why?
|
| Cell Line, Tumor | 17 | 2024 | 1259 | 0.930 |
Why?
|
| Genome-Wide Association Study | 6 | 2025 | 238 | 0.900 |
Why?
|
| Animals | 26 | 2024 | 9954 | 0.840 |
Why?
|
| Bone Neoplasms | 2 | 2023 | 27 | 0.820 |
Why?
|
| Lung Neoplasms | 3 | 2021 | 339 | 0.790 |
Why?
|
| Oxadiazoles | 1 | 2021 | 3 | 0.760 |
Why?
|
| Breast Neoplasms | 3 | 2023 | 441 | 0.750 |
Why?
|
| Quantitative Trait Loci | 4 | 2025 | 57 | 0.740 |
Why?
|
| Interleukin-1beta | 1 | 2021 | 40 | 0.740 |
Why?
|
| Antineoplastic Agents | 4 | 2021 | 656 | 0.720 |
Why?
|
| Mice | 16 | 2024 | 4402 | 0.720 |
Why?
|
| Beclin-1 | 2 | 2017 | 4 | 0.710 |
Why?
|
| Pyrimidines | 1 | 2021 | 121 | 0.700 |
Why?
|
| Ribonuclease III | 1 | 2019 | 6 | 0.650 |
Why?
|
| Microphthalmia-Associated Transcription Factor | 1 | 2019 | 7 | 0.650 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2019 | 26 | 0.630 |
Why?
|
| Myeloid Cell Leukemia Sequence 1 Protein | 1 | 2018 | 6 | 0.620 |
Why?
|
| Xenograft Model Antitumor Assays | 6 | 2024 | 250 | 0.590 |
Why?
|
| Humans | 34 | 2024 | 26856 | 0.580 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2018 | 148 | 0.570 |
Why?
|
| Recombinant Proteins | 1 | 2018 | 408 | 0.560 |
Why?
|
| Signal Transduction | 7 | 2023 | 1339 | 0.550 |
Why?
|
| Neoplasm Metastasis | 4 | 2023 | 151 | 0.540 |
Why?
|
| Disease Resistance | 4 | 2023 | 18 | 0.530 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2021 | 443 | 0.510 |
Why?
|
| Autophagy | 4 | 2021 | 69 | 0.500 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2025 | 544 | 0.490 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2014 | 13 | 0.470 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2013 | 13 | 0.440 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2013 | 9 | 0.440 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2013 | 16 | 0.430 |
Why?
|
| Promoter Regions, Genetic | 2 | 2011 | 332 | 0.420 |
Why?
|
| Colorectal Neoplasms | 1 | 2014 | 133 | 0.410 |
Why?
|
| Glioma | 3 | 2018 | 118 | 0.400 |
Why?
|
| Reactive Oxygen Species | 3 | 2019 | 277 | 0.400 |
Why?
|
| Plant Breeding | 4 | 2024 | 6 | 0.390 |
Why?
|
| Down-Regulation | 3 | 2019 | 196 | 0.390 |
Why?
|
| Mice, Nude | 4 | 2024 | 312 | 0.380 |
Why?
|
| Plant Diseases | 4 | 2023 | 36 | 0.370 |
Why?
|
| Sirtuin 1 | 1 | 2011 | 39 | 0.370 |
Why?
|
| MDS1 and EVI1 Complex Locus Protein | 4 | 2014 | 4 | 0.350 |
Why?
|
| Neoplasm Invasiveness | 3 | 2019 | 180 | 0.340 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2023 | 146 | 0.320 |
Why?
|
| Brain Neoplasms | 3 | 2024 | 288 | 0.320 |
Why?
|
| Small Molecule Libraries | 2 | 2019 | 17 | 0.320 |
Why?
|
| Phenotype | 4 | 2025 | 664 | 0.310 |
Why?
|
| Edible Grain | 2 | 2025 | 5 | 0.300 |
Why?
|
| Tumor Microenvironment | 5 | 2023 | 144 | 0.300 |
Why?
|
| Neoplastic Stem Cells | 3 | 2018 | 139 | 0.290 |
Why?
|
| Polyploidy | 2 | 2024 | 12 | 0.290 |
Why?
|
| Neuroblastoma | 2 | 2019 | 56 | 0.290 |
Why?
|
| Skin Neoplasms | 2 | 2021 | 128 | 0.280 |
Why?
|
| Transcription, Genetic | 3 | 2014 | 399 | 0.280 |
Why?
|
| Chromosome Mapping | 2 | 2023 | 131 | 0.260 |
Why?
|
| Genetic Variation | 2 | 2024 | 229 | 0.260 |
Why?
|
| Adenoviridae | 2 | 2024 | 65 | 0.260 |
Why?
|
| Thermotolerance | 1 | 2025 | 4 | 0.250 |
Why?
|
| Heat-Shock Response | 1 | 2025 | 13 | 0.250 |
Why?
|
| HEK293 Cells | 3 | 2021 | 173 | 0.230 |
Why?
|
| Blood-Brain Barrier | 1 | 2024 | 82 | 0.220 |
Why?
|
| Genotype | 4 | 2025 | 443 | 0.220 |
Why?
|
| Integrin beta1 | 1 | 2023 | 15 | 0.210 |
Why?
|
| Inflammation | 2 | 2018 | 598 | 0.210 |
Why?
|
| Ascomycota | 1 | 2022 | 21 | 0.210 |
Why?
|
| Cell Proliferation | 4 | 2019 | 770 | 0.200 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2023 | 125 | 0.200 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2019 | 37 | 0.200 |
Why?
|
| Aloe | 1 | 2021 | 1 | 0.200 |
Why?
|
| Anoikis | 2 | 2018 | 3 | 0.190 |
Why?
|
| Osmoregulation | 1 | 2021 | 1 | 0.190 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2021 | 49 | 0.190 |
Why?
|
| Interleukin-23 Subunit p19 | 1 | 2021 | 1 | 0.190 |
Why?
|
| Chemokine CCL17 | 1 | 2021 | 1 | 0.190 |
Why?
|
| Interleukin-5 | 1 | 2021 | 2 | 0.190 |
Why?
|
| Acetylation | 2 | 2011 | 36 | 0.190 |
Why?
|
| Chemokine CCL11 | 1 | 2021 | 3 | 0.190 |
Why?
|
| Interleukin-1alpha | 1 | 2021 | 7 | 0.190 |
Why?
|
| Male | 8 | 2023 | 12866 | 0.190 |
Why?
|
| T-Lymphocytes | 2 | 2021 | 274 | 0.190 |
Why?
|
| Cell Engineering | 1 | 2021 | 1 | 0.190 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2021 | 30 | 0.190 |
Why?
|
| Adoptive Transfer | 1 | 2021 | 25 | 0.190 |
Why?
|
| Peptides | 1 | 2023 | 280 | 0.190 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2021 | 14 | 0.190 |
Why?
|
| Plant Roots | 1 | 2021 | 46 | 0.190 |
Why?
|
| Tumor Burden | 1 | 2021 | 108 | 0.180 |
Why?
|
| Interleukin-10 | 1 | 2021 | 67 | 0.180 |
Why?
|
| STAT3 Transcription Factor | 2 | 2018 | 86 | 0.180 |
Why?
|
| Mice, Inbred BALB C | 1 | 2021 | 264 | 0.180 |
Why?
|
| Up-Regulation | 2 | 2011 | 239 | 0.180 |
Why?
|
| Bread | 3 | 2025 | 3 | 0.170 |
Why?
|
| Female | 8 | 2023 | 14462 | 0.170 |
Why?
|
| Cell Differentiation | 2 | 2019 | 395 | 0.170 |
Why?
|
| Protein Binding | 2 | 2011 | 631 | 0.170 |
Why?
|
| RAW 264.7 Cells | 1 | 2018 | 21 | 0.150 |
Why?
|
| Receptors, Somatomedin | 1 | 2018 | 4 | 0.150 |
Why?
|
| Disease | 1 | 2018 | 15 | 0.150 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2018 | 32 | 0.150 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2017 | 20 | 0.150 |
Why?
|
| Pancreatic Neoplasms | 1 | 2023 | 505 | 0.140 |
Why?
|
| Oncogenes | 1 | 2017 | 34 | 0.140 |
Why?
|
| Evolution, Molecular | 1 | 2017 | 80 | 0.140 |
Why?
|
| Genetic Therapy | 1 | 2018 | 116 | 0.140 |
Why?
|
| Protein Biosynthesis | 1 | 2017 | 106 | 0.140 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2014 | 323 | 0.140 |
Why?
|
| Anthraquinones | 1 | 2016 | 4 | 0.140 |
Why?
|
| Receptors, Somatostatin | 1 | 2016 | 8 | 0.140 |
Why?
|
| Molecular Targeted Therapy | 1 | 2017 | 123 | 0.130 |
Why?
|
| Apoptosis Inducing Factor | 1 | 2016 | 2 | 0.130 |
Why?
|
| Melanoma, Experimental | 1 | 2016 | 29 | 0.130 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2016 | 15 | 0.130 |
Why?
|
| Sirolimus | 1 | 2016 | 68 | 0.130 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2016 | 109 | 0.130 |
Why?
|
| Liposomes | 1 | 2016 | 142 | 0.130 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2013 | 27 | 0.120 |
Why?
|
| Transcriptional Activation | 2 | 2013 | 86 | 0.120 |
Why?
|
| Mice, Knockout | 2 | 2016 | 781 | 0.120 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2014 | 18 | 0.120 |
Why?
|
| Filariasis | 1 | 2014 | 1 | 0.120 |
Why?
|
| Wuchereria bancrofti | 1 | 2014 | 1 | 0.120 |
Why?
|
| Brugia pahangi | 1 | 2014 | 1 | 0.120 |
Why?
|
| Antigens, Helminth | 1 | 2014 | 10 | 0.120 |
Why?
|
| HCT116 Cells | 1 | 2014 | 53 | 0.120 |
Why?
|
| Vitamin D | 1 | 2014 | 44 | 0.110 |
Why?
|
| Interferon-alpha | 1 | 2014 | 50 | 0.110 |
Why?
|
| SUMO-1 Protein | 1 | 2013 | 1 | 0.110 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2014 | 69 | 0.110 |
Why?
|
| Arsenicals | 1 | 2013 | 5 | 0.110 |
Why?
|
| Oxides | 1 | 2013 | 14 | 0.110 |
Why?
|
| Blotting, Western | 2 | 2013 | 503 | 0.110 |
Why?
|
| Alleles | 2 | 2024 | 347 | 0.110 |
Why?
|
| Monocytes | 1 | 2014 | 132 | 0.100 |
Why?
|
| Cell Movement | 3 | 2019 | 353 | 0.100 |
Why?
|
| HT29 Cells | 1 | 2011 | 19 | 0.100 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2011 | 13 | 0.100 |
Why?
|
| Zinc Fingers | 1 | 2011 | 26 | 0.100 |
Why?
|
| NIH 3T3 Cells | 1 | 2011 | 44 | 0.100 |
Why?
|
| Interleukin-6 | 3 | 2018 | 190 | 0.090 |
Why?
|
| K562 Cells | 1 | 2011 | 20 | 0.090 |
Why?
|
| RNA Interference | 1 | 2011 | 135 | 0.090 |
Why?
|
| Mice, Transgenic | 2 | 2023 | 487 | 0.090 |
Why?
|
| Dogs | 1 | 2011 | 504 | 0.090 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2011 | 98 | 0.090 |
Why?
|
| Cell Death | 2 | 2021 | 110 | 0.090 |
Why?
|
| Base Sequence | 1 | 2011 | 573 | 0.090 |
Why?
|
| India | 2 | 2025 | 137 | 0.090 |
Why?
|
| Cattle | 1 | 2011 | 383 | 0.080 |
Why?
|
| Molecular Sequence Data | 1 | 2011 | 1036 | 0.080 |
Why?
|
| Receptor, IGF Type 1 | 2 | 2019 | 40 | 0.080 |
Why?
|
| Rats | 1 | 2011 | 1536 | 0.070 |
Why?
|
| Ovarian Neoplasms | 1 | 2013 | 563 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2018 | 176 | 0.070 |
Why?
|
| Carcinogenesis | 2 | 2018 | 79 | 0.070 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2014 | 986 | 0.070 |
Why?
|
| Tumor Cells, Cultured | 2 | 2018 | 310 | 0.060 |
Why?
|
| Nucleotides | 1 | 2025 | 19 | 0.060 |
Why?
|
| Genetic Markers | 1 | 2025 | 93 | 0.060 |
Why?
|
| Zinc | 1 | 2025 | 53 | 0.060 |
Why?
|
| Genetics, Population | 1 | 2024 | 72 | 0.060 |
Why?
|
| Microbubbles | 1 | 2024 | 5 | 0.060 |
Why?
|
| Oncolytic Virotherapy | 1 | 2024 | 12 | 0.060 |
Why?
|
| Poly C | 1 | 2023 | 1 | 0.060 |
Why?
|
| Crops, Agricultural | 1 | 2023 | 15 | 0.060 |
Why?
|
| Genetic Vectors | 1 | 2024 | 107 | 0.060 |
Why?
|
| Cytoplasm | 1 | 2023 | 57 | 0.060 |
Why?
|
| STAT1 Transcription Factor | 1 | 2023 | 37 | 0.060 |
Why?
|
| Chemokine CCL2 | 1 | 2023 | 43 | 0.050 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2023 | 8 | 0.050 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2014 | 129 | 0.050 |
Why?
|
| Glioblastoma | 1 | 2024 | 95 | 0.050 |
Why?
|
| Molecular Docking Simulation | 1 | 2021 | 46 | 0.050 |
Why?
|
| Droughts | 1 | 2021 | 22 | 0.050 |
Why?
|
| Plant Extracts | 1 | 2021 | 62 | 0.050 |
Why?
|
| Genomics | 1 | 2022 | 116 | 0.050 |
Why?
|
| Protein Kinases | 1 | 2022 | 143 | 0.050 |
Why?
|
| Gene Expression Profiling | 1 | 2023 | 437 | 0.050 |
Why?
|
| Antigens, Neoplasm | 1 | 2021 | 50 | 0.050 |
Why?
|
| Transfection | 1 | 2021 | 312 | 0.040 |
Why?
|
| DNA | 1 | 2021 | 365 | 0.040 |
Why?
|
| Biomarkers | 1 | 2023 | 731 | 0.040 |
Why?
|
| Integrins | 1 | 2019 | 27 | 0.040 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2019 | 23 | 0.040 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 2019 | 26 | 0.040 |
Why?
|
| Protein Domains | 1 | 2019 | 48 | 0.040 |
Why?
|
| Binding Sites | 1 | 2019 | 338 | 0.040 |
Why?
|
| Macrophage Migration-Inhibitory Factors | 1 | 2018 | 8 | 0.040 |
Why?
|
| Interleukin-8 | 1 | 2018 | 44 | 0.040 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2018 | 40 | 0.040 |
Why?
|
| Breast | 1 | 2018 | 51 | 0.040 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2018 | 54 | 0.040 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2018 | 57 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2016 | 5 | 0.030 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2016 | 28 | 0.030 |
Why?
|
| Myeloid-Derived Suppressor Cells | 1 | 2016 | 6 | 0.030 |
Why?
|
| Receptor, Notch1 | 1 | 2016 | 25 | 0.030 |
Why?
|
| Melanocytes | 1 | 2016 | 15 | 0.030 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2016 | 31 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2016 | 40 | 0.030 |
Why?
|
| Interleukin-17 | 1 | 2016 | 51 | 0.030 |
Why?
|
| Caspases | 1 | 2016 | 42 | 0.030 |
Why?
|
| Th17 Cells | 1 | 2016 | 32 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2021 | 1474 | 0.030 |
Why?
|
| Lymphatic Metastasis | 1 | 2016 | 119 | 0.030 |
Why?
|
| Lymph Nodes | 1 | 2016 | 95 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2018 | 309 | 0.030 |
Why?
|
| Histones | 1 | 2016 | 90 | 0.030 |
Why?
|
| Astrocytes | 1 | 2016 | 73 | 0.030 |
Why?
|
| Immune Tolerance | 1 | 2014 | 49 | 0.030 |
Why?
|
| Vitamin D Deficiency | 1 | 2014 | 27 | 0.030 |
Why?
|
| Lung | 1 | 2016 | 346 | 0.030 |
Why?
|
| Sumoylation | 1 | 2013 | 2 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 1 | 2013 | 65 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 254 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2013 | 110 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2013 | 67 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2013 | 129 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2014 | 282 | 0.030 |
Why?
|
| Mutation | 1 | 2016 | 820 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2014 | 860 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2013 | 645 | 0.020 |
Why?
|
| Adult | 1 | 2014 | 7389 | 0.010 |
Why?
|